NARG1L Recombinant antibody

NARG1L Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 85860-4-RR
Clone No.250181F4

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, ELISA

NAA16, N-alpha-acetyltransferase 16, NatA auxiliary subunit, NARG1 like protein, NARG1-like protein, NAT2

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inHeLa cells, Jurkat cells, A549 cells, SH-SY5Y cells, mouse spleen tissue, rat brain tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

85860-4-RR targets NARG1L in WB, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen NARG1L fusion protein Ag11492 Predict reactive species
Full Name NMDA receptor regulated 1-like
Calculated Molecular Weight 864 aa, 101 kDa
Observed Molecular Weight101 kDa
GenBank Accession NumberBC028112
Gene Symbol NARG1L
Gene ID (NCBI) 79612
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDQ6N069
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

NMDA receptor-regulated 1-like protein (NARG1L, also known as NAA16), is the auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity.

Protocols

Product Specific Protocols
WB protocol for NARG1L antibody 85860-4-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...